Literature DB >> 4328325

6-Methylthioguanylic acid, a metabolite of 6-thioguanine.

P W Allan, L L Bennett.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4328325     DOI: 10.1016/0006-2952(71)90046-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  6 in total

1.  Phase II trial of 5 day continuous intravenous infusion of 6-thioguanine in patients with recurrent and metastatic squamous cell carcinoma of the head and neck.

Authors:  F Kruter; M Eisenberger; V Sinibaldi; C Engstrom; M Jacobs; J Abrams; C Belani; W Gray; S Krasnow
Journal:  Invest New Drugs       Date:  1992-07       Impact factor: 3.850

Review 2.  Very important pharmacogene summary: thiopurine S-methyltransferase.

Authors:  Liewei Wang; Linda Pelleymounter; Richard Weinshilboum; Julie A Johnson; Joan M Hebert; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2010-06       Impact factor: 2.089

3.  Phase II study of intravenous 6-thioguanine in patients with advanced gastric carcinoma.

Authors:  J A Ajani; R Pazdur; R J Winn; J L Abbruzzese; B Levin; C Wiseman; M A Lenado-Lee; Y Z Patt; I H Krakoff
Journal:  Invest New Drugs       Date:  1991-08       Impact factor: 3.850

4.  Phase II study of intravenous 6-thioguanine in patients with advanced carcinoma of the pancreas.

Authors:  J A Ajani; R Pazdur; R J Winn; J L Abbruzzese; B Levin; R Belt; J Young; Y Z Patt; I H Krakoff
Journal:  Invest New Drugs       Date:  1991-11       Impact factor: 3.850

5.  Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel disease.

Authors:  U Hindorf; M Lindqvist; C Peterson; P Söderkvist; M Ström; H Hjortswang; A Pousette; S Almer
Journal:  Gut       Date:  2006-03-16       Impact factor: 23.059

Review 6.  Clinical pharmacology and pharmacogenetics of thiopurines.

Authors:  Srikumar Sahasranaman; Danny Howard; Sandip Roy
Journal:  Eur J Clin Pharmacol       Date:  2008-05-28       Impact factor: 3.064

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.